- 101. N
- [The non-affirmative response to a question. (NCI) ( NCI )] (UMLS (NCI) C1298908) No;
=Finding | - 151. N-TRAF BRD/ALIT-PEDEST
- [ ] (UMLS (ICD9CM) C0261186) =Phenomenon or Process
|
- 102. N acetyl glutamate synthetase deficiency
- [ ] (UMLS (CSP) C0268543) =Disease or Syndrome
| - 152. N-TRAF BRD/ALIT-PERS NEC
- [ ] (UMLS (ICD9CM) C0261187) =Phenomenon or Process
|
- 103. N acetyl glutamate synthethase deficiency
- [ ] (UMLS (CSP) C0598385) =Pathologic Function
| - 153. N-TRAF BRD/ALIT-PERS NOS
- [ ] (UMLS (ICD9CM) C0261188) =Phenomenon or Process
|
- 104. N acetyl L glutamate
- [ ] (UMLS (CSP) C0067724) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 154. N-TRAF BRD/ALIT-ST CAR
- [ ] (UMLS (ICD9CM) C0261183) =Phenomenon or Process
|
- 105. N acetylgalactosamine
- [N-acetyl derivative of galactosamine. ( CSP )] (UMLS (CSP) C0001055) =Carbohydrate; Biologically Active Substance ;
| - 155. N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]acetamide
- (UMLS (NCI) C0083632) =Organic Chemical; Pharmacologic Substance
|
- 106. N acetylglucosamine
- [N-acetyl derivative of glucosamine. ( CSP )] (UMLS (CSP) C0001056) =Carbohydrate; Biologically Active Substance ;
| - 156. N-[(5S)-6,7-Dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide
- (UMLS (NCI) C1122628) N-acetylcochinol-O-phosphate =Organic Chemical; Pharmacologic Substance ;
|
- 107. N acetylglucosaminidase
- [ ] (UMLS (CSP) C0699917) =Amino Acid, Peptide, or Protein; Enzyme =O glycosidase;
| - 157. N-[1-(2-Cyano-2-deoxy-beta-D-arabinofuranosyl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide
- [An orally bioavailable pyrimidine analog with potential antineoplastic activity. Sapacitabine is hydrolyzed by amidases to the deoxycytosine analog CNDAC (2'-Cyano-2'-deoxyarabinofuranosylcytosine), which is then phosphorylated into its active triphosphate form. As an analog of deoxycytidine triphosphate, CNDAC triphosphate molecules get incorporated into DNA strands during replication, thereby leading to single-stranded DNA breaks caused by beta-elimination in fidelity check point. As a result, this agent induces cell cycle arrest in the G2 phase and subsequently triggers apoptosis. ( NCI )] (UMLS (NCI) C0764827) Sapacitabine;
=Organic Chemical |
- 108. N acetylhexosamine
- [ ] (UMLS (CSP) C0597000) =Carbohydrate
| - 158. N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
- (UMLS (NCI) C0656780) =Organic Chemical; Pharmacologic Substance ;
|
- 109. N acetylneuraminate
- [N-acetyl derivative of the amino sugar neuraminic acid; the most common of the sialic acids; occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. ( CSP )] (UMLS (CSP) C0178446) =Carbohydrate ;
=sialate;
| - 159. N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
- [N-2-(5-dimethylamino)methyl-2- furanylmethyl thioethyl-N'-methyl-2-nitro-1,1 -ethenediamine; cimetidine analog; H2 histamine receptor antagonist used to treat gastric ulcers. ( CSP )] (UMLS (NCI) C0034665) =Organic Chemical; Pharmacologic Substance ;
=[GA300] ANTIULCER AGENTS;
Furans;
[GA301] HISTAMINE ANTAGONISTS;
1,4-Epoxy-1,3-butadiene;
[GA303] H.PYLORI AGENTS;
=N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, compound with bismuth(3(+)) citrate (1:1);
N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride;
N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, compound with bismuth(3(+)) citrate (1:1);
N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride;
RANITIDINE 75 MG |
- 110. N acylaminoacid
- [ ] (UMLS (CSP) C0597001) =Amino Acid, Peptide, or Protein =aa;
| - 160. N-[[4-[Bis(2-iodoethyl)amino]phenoxy]carbonyl]-L-glutamic Acid
- (UMLS (NCI) C0385703) =Organic Chemical; Pharmacologic Substance ;
|
- 111. N acylation
- [ ] (UMLS (CSP) C0597002) =Phenomenon or Process =acylation;
| - 161. N01
- (UMLS (HL7) C1579933) =Intellectual Product =Message structure;
|
- 112. N alkylaminoacid
- [ ] (UMLS (CSP) C0597003) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 162. N02
- (UMLS (HL7) C1549813) =Intellectual Product =Message structure;
|
- 113. N carbamoylaminoacid
- [ ] (UMLS (CSP) C0597004) =Amino Acid, Peptide, or Protein
| - 163. N13 isotope
- [ ] (UMLS (CSP) C0302959) =Biologically Active Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
|
- 114. N element
- [use this term only for the element N or the gas N2; for other nitrogen compounds see NITROGEN COMPOUND. ( CSP )] (UMLS (CSP) C0028158) =Element, Ion, or Isotope ;
=Element;
Gas;
nitrogen compound;
[RE600] NON-ANESTHETIC GASES =NITROGEN 99 %;
NITROGEN 68.7 %;
NITROGEN 1.3 GM/100ML;
NITROGEN 1.8 %;
NITROGEN 11 MG/ML;
NITROGEN 11.2 MG/ML;
NITROGEN 13 MG/ML;
NITROGEN 13.4 MG/ML;
NITROGEN 15.2 MG/ML;
NITROGEN 15.3 MG/ML;
NITROGEN 2.37 %;
NITROGEN 5.35 MG/ML;
NITROGEN 5.4 MG/ML;
NITROGEN 6.5 MG/ML;
NITROGEN 7.7 MG/ML;
NITROGEN 95 %VV;
NITROGEN 91 %VV;
NITROGEN 72 %VV | - 164. N15 isotope
- [ ] (UMLS (CSP) C0599470) =Biologically Active Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
|
- 115. N glycosidase
- [ ] (UMLS (CSP) C0597005) =Amino Acid, Peptide, or Protein; Enzyme ;
=glycosidase;
=DPN hydrolase;
| - 165. N33
- [Expressed in most nonlymphoid tissues including prostate, lung, liver, and colon by human N33 Gene (OST3 Family), 348-aa 40-kDa N33 Protein is a potential integral membrane protein. (NCI) ( NCI )] (UMLS (NCI) C1334860) N33 Protein;
TUSC3;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 116. N hydroxyacetylaminofluorene
- [A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action. ( MSH )] (UMLS (CSP) C0020319) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 166. N43 grant
- [ ] (UMLS (CSP) C1657760) =Governmental or Regulatory Activity ;
|
- 117. N hydroxylation
- [ ] (UMLS (CSP) C0597006) =Phenomenon or Process =hydroxylation;
| - 167. N44 grant
- [ ] (UMLS (CSP) C1658276) =Governmental or Regulatory Activity ;
|
- 118. N methyl D aspartate
- [An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA). ( MSH )] (UMLS (CSP) C0079883) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 168. NA
- [A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI) ( NCI )] (UMLS (NCI) C0027366) =Geographic Area
|
- 119. N methyl D aspartate receptor
- [subtype of glutamate receptor to which the synthetic aminoacid NMDA is an agonist; effectors are ligand- and voltage-gated calcium channel domains or subunits; important in excitotoxicity and neural plasticity. ( CSP )] (UMLS (CSP) C0080093) =Amino Acid, Peptide, or Protein; Receptor =calcium channel;
glutamate receptor | - 169. NA
- [A measurement of the sodium in a biological specimen. ( NCI )] (UMLS (NCI) C0337443) =Laboratory Procedure
|
- 120. N methylaminoacid
- [ ] (UMLS (CSP) C0597007) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 170. Na+ element
- [chief cation of the extracellular body fluids. ( CSP )] (UMLS (CSP) C0597484) =Pharmacologic Substance =ion;
|
- 121. N methylnicotinamide
- [ ] (UMLS (CSP) C0068144) =Organic Chemical ;
| - 171. Na/H exchanger
- [plasma membrane exchange glycoprotein transporters that function in intracellular pH regulation, cell volume regulation and cellular response to many different hormones and mitogens. ( CSP )] (UMLS (CSP) C0074785) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=membrane transport protein;
|
- 122. N phosphonoacetyl L aspartate
- [An anticancer drug that is being studied to increase the effectiveness of the chemotherapy drug fluorouracil. ( NCI )] (UMLS (CSP) C0135096) =Organophosphorus Compound; Pharmacologic Substance ;
=antimetabolite;
[AN000] ANTINEOPLASTICS;
dicarboxylate;
| - 172. NA17-A
- [A specific melanoma antigen protein derived from a patient (NA17) with cutaneous melanoma metastases. The NA17-A antigen is part of the enzyme N-acetyl glucosaminyl-transferase V (GnT-V). Approximately half of melanomas have been found to express significant levels of this atypical protein, which is not expressed by normal tissues. When administered in a vaccine formulation, NA17-A antigen may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. ( NCI )] (UMLS (NCI) C1134655) NA17-A Antigen =Pharmacologic Substance; Immunologic Factor ;
|
- 123. N,N,N',N',N"-pentamethyl-1,3,5-triazine
- [A principal metabolite of hexamethylmelamine with antineoplastic activity. Pentamethylmelamine alkylates DNA and other macromolecules and forms DNA intrastrand and DNA-protein crosslinks, thereby preventing DNA replication. (NCI04) ( NCI )] (UMLS (NCI) C0070302) =Organic Chemical; Pharmacologic Substance ;
| - 173. Na24 isotope
- [ ] (UMLS (CSP) C0303512) =Element, Ion, or Isotope
|
- 124. N,N-bis(carboxymethoxy)glycine
- [A white, crystalline solid compound. Nitrilotriacetic acid is mainly used as a chelating and eluting agent and is found in laundry detergents. Exposure to Nitrilotriacetic acid irritates the skin, eyes and respiratory tract and causes kidney and bladder damage. Nitrilotriacetic acid is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0028132) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 174. NAACCR
- [NAACCR Cancer Registry ( HL7V3.0 )] (UMLS (HL7) C1553865) =Intellectual Product =CodeSystem;
|
- 125. N,N-Dibenzyl Daunomycin
- [The N-alkylated analogue of the anthracycline antineoplastic antibiotic daunomycin. N,N-Dibenzyl Daunomycin interacts with topoisomerase II, thereby inhibiting DNA replication and repair and promoting DNA fragmentation. This agent is less cardiotoxic than daunomycin. (NCI04) ( NCI )] (UMLS (NCI) C0067345) =Organic Chemical; Pharmacologic Substance
| - 175. Nabesna
- (UMLS (HL7) C1551908) Upper Tanana;
=Language =Tanana;
|
- 126. N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide
- (UMLS (NCI) C0299218) =Organic Chemical; Pharmacologic Substance ;
| - 176. NABI
- (UMLS (HL7) C1546882) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
|
- 127. N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-
- [A semi-synthetic derivative of pristinamycin, a natural occurring type B streptogramin. Quinupristin binds to the bacterial 50S ribosomal subunit, thereby inhibiting peptide chain elongation, and causing early termination of normal bacterial protein synthesis. Quinupristin is primarily effective against gram-positive cocci. ( NCI )] (UMLS (NCI) C0756081) Quinupristin;
QUINUPRISTIN PREPARATION;
Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic Acid)-,(S)-;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance =Mikamycin;
[AM900] ANTI-INFECTIVES, OTHER =QUINUPRISTIN 150 MG;
| - 177. NABI (formerly North American Biologicals, Inc.)
- [NABI (formerly North American Biologicals, Inc.) ( HL7V3.0 )] (UMLS (HL7) C1552896) =Health Care Related Organization ;
=VaccineManufacturer;
|
- 128. N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride
- [A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked. ( NCI )] (UMLS (NCI) C0700466) =Organic Chemical; Pharmacologic Substance =N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine;
=RANITIDINE HYDROCHLORIDE 300 MG;
RANITIDINE HYDROCHLORIDE 50 MG;
RANITIDINE HYDROCHLORIDE 25 MG/ML;
RANITIDINE HYDROCHLORIDE 75 MG/5ML;
RANITIDINE HYDROCHLORIDE 0.5 MG/ML;
RANITIDINE HYDROCHLORIDE 150 MG;
| - 178. NABILONE
- [A synthetic cannabinoid and dibenzopyrane derivative with anti-emetic activity. Although the mechanism of action has not been fully elucidated yet, it has been suggested that nabilone is a highly selective and strong agonist for the cannabinoid receptors CB1 and CB2, both of which are coupled to Gi/o proteins. The CB1 receptors are expressed predominantly in central and peripheral neurons and receptor stimulation has been implicated in the reduction of chemotherapy-induced nausea. ( NCI )] (UMLS (NCI) C0068333) =Organic Chemical; Pharmacologic Substance ;
=[GA700] ANTIEMETICS;
(-)-.DELTA.9-Tetrahydrocannabinol |
- 129. N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, compound with bismuth(3(+)) citrate (1:1)
- [A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked. ( NCI )] (UMLS (NCI) C0139919) =Organic Chemical; Pharmacologic Substance =Bi element;
N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine =RANITIDINE BISMUTH CITRATE 400 MG | - 179. Nabothian Cyst
- (UMLS (NCI) C0027269) =Disease or Syndrome
|
- 130. N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine
- [A synthetic, dibenzamine alpha-adrenergic antagonist with antihypertensive and vasodilatory properties. Phenoxybenzamine non-selectively and irreversibly blocks the postsynaptic alpha-adrenergic receptor in smooth muscle, thereby preventing vasoconstriction, relieving vasospasms, and decreasing peripheral resistance. Reflex tachycardia may occur and may be enhanced by blockade of alpha2 receptors which enhances norepinephrine release. Phenoxybenzamine is reasonably anticipated to be a human carcinogen. ( NCI )] (UMLS (NCI) C0031441) =Organic Chemical; Pharmacologic Substance ;
=Ethylamines;
sympatholytic agent =PHENOXYBENZAMINE HYDROCHLORIDE | - 180. NAD analog
- [ ] (UMLS (CSP) C0920599) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 131. N-(2-Dimethylaminopropyl-1)phenothiazine Hydrochloride
- [The hydrochloride salt form of promethazine, a phenothiazine derivative with antihistaminic, sedative and antiemetic properties. Promethazine hydrochloride selectively blocks peripheral H1 receptors thereby diminishing the effects of histamine on effector cells. Promethazine hydrochloride also blocks the central histaminergic receptors, thereby depressing the reticular system causing sedative and hypnotic effects. In addition, promethazine hydrochloride also has centrally acting anticholinergic properties and probably mediates nausea and vomiting by acting on the medullary chemoreceptive trigger zone. ( NCI )] (UMLS (NCI) C0546876) =Organic Chemical; Pharmacologic Substance =PROMETHAZINE;
=PROMETHAZINE HYDROCHLORIDE 25 MG;
PROMETHAZINE HYDROCHLORIDE 6.25 MG/5ML;
PROMETHAZINE HYDROCHLORIDE 625 MG/5ML;
PROMETHAZINE HYDROCHLORIDE 25 MG/ML;
PROMETHAZINE HYDROCHLORIDE 50 MG/ML;
PROMETHAZINE HYDROCHLORIDE 5 MG;
PROMETHAZINE HYDROCHLORIDE 6.25 MG;
PROMETHAZINE HYDROCHLORIDE 12.5 MG;
PROMETHAZINE HYDROCHLORIDE 50 MG;
PROMETHAZINE HYDROCHLORIDE 25 MG/5ML;
PROMETHAZINE HYDROCHLORIDE 5 MG/5ML;
PROMETHAZINE HYDROCHLORIDE 6.2 MG | - 181. NAD kinase
- [ ] (UMLS (CSP) C0068337) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
|
- 132. N-(4-Methoxyphenyl)retinamide
- (UMLS (NCI) C0067544) =Organic Chemical ;
| - 182. NAD phosphate
- [nicotinamide adenine dinucleotide phosphate; a coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate; serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced ( NADPH). ( CSP )] (UMLS (CSP) C0027303) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=adenine nucleotide;
cofactor;
high energy compound;
nicotinamide ribotide |
- 133. N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide
- [A nonsteroidal arylsulfonamide with anti-inflammatory properties. Nimesulide inhibits the cyclooxygenase-mediated conversion of arachidonic acid to pro-inflammatory prostaglandins. Modestly selective for COX-2, this agent binds to the enzyme, thereby inactivating it. Nimesulide may inhibit some carcinogenic COX-2-related carcinogenic effects on xenobiotic metabolism, apoptosis, immune surveillance and angiogenesis (overexpressed COX-2 in tumor epithelial cells enhances production of vascular growth factors and the formation of capillary-like networks). (NCI04) ( NCI )] (UMLS (NCI) C0132515) =Organic Chemical; Pharmacologic Substance ;
| - 183. NAD transhydrogenase
- [An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy (ATP) it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1. ( MSH )] (UMLS (CSP) C0027307) =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
|
- 134. N-(5-[N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic Acid
- [An anticancer drug that inhibits tumor cells from multiplying by interfering with cells' ability to make DNA. ( NCI )] (UMLS (NCI) C0677667) =Organic Chemical; Pharmacologic Substance
| - 184. NAD(+) ADP ribosyltransferase
- [An enzyme that catalyze the transfer of ADP-RIBOSE from NAD+ to an amino acid residue in a specific protein substrate. This reaction is catalyzed by both mono(ADP-ribose) transferases as well as POLY(ADP-RIBOSE) POLYMERASES. When the term NAD+ ADP-Ribosyltransferase refers to EC 2.4.2.30 it is referring to POLY(ADP-RIBOSE) POLYMERASES. ( MSH )] (UMLS (CSP) C1138564) =Amino Acid, Peptide, or Protein; Enzyme
|
- 135. N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine Monohydrochloride
- [The hydrochloride salt form of tirofiban, a non-peptide tyrosine derivative with anticoagulant property. Tirofiban antagonizes fibrinogen binding to the platelet cell surface receptor, glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP. The antagonism prevents adenylyl cyclase activation, which mediated via GP IIb/IIIa receptor complex, and results in decreased levels of cAMP and thereby interferes with platelet membrane function and subsequent platelet-platelet interaction, release of platelet granule constituents and prolongation of bleeding time. ( NCI )] (UMLS (NCI) C0795668) Tirofiban Hydrochloride;
TIROFIBAN HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=tirofiban;
=TIROFIBAN HYDROCHLORIDE 250 MCG/ML;
TIROFIBAN HYDROCHLORIDE 50 MCG/ML;
| - 185. NAD(H) analog
- [synthetic or natural compounds which resemble the coenzyme nicotinamide adenine dinucleotide in structure and/or function. ( CSP )] (UMLS (CSP) C0597009) =Nucleic Acid, Nucleoside, or Nucleotide =nucleotide analog;
|
- 136. N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-Tyrosine
- [A synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. This agent also augments the effects of ionizing radiation by arresting cancer cells in the G2/M phase of the cell cycle. (NCI04) ( NCI )] (UMLS (NCI) C0080225) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 186. NAD(P)H Dehydrogenase, Quinone 1 Gene
- [This gene is involved in drug/xenobiotic metabolism, biosynthetic processes and the prevention of cellular oxidative stress. ( NCI )] (UMLS (NCI) C0919428) NQO1;
NQO1 Gene =Gene or Genome ;
|
- 137. N-137
- (UMLS (NCI) C0068482) =Organic Chemical; Pharmacologic Substance
| - 187. NAD(P)H oxidoreductase
- [A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. ( MSH )] (UMLS (CSP) C0027298) =Amino Acid, Peptide, or Protein; Enzyme ;
=dehydrogenase;
=glutathione reductase;
NAD transhydrogenase;
nitrate reductase;
cytochrome b5 reductase;
FMN reductase;
NADPH cytochrome c2 reductase;
hydrogen peroxide generating oxidase |
- 138. N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) Gene
- [This gene plays a role in both the activation and deactivation of xenobiotics. ( NCI )] (UMLS (NCI) C0796518) NAT2;
NAT2 Gene;
=Gene or Genome | - 188. NADE
- [Cloned by its ability to interact with the death domain of nerve growth factor receptor. Likely to be involved in nerve growth factor-mediated apoptosis. (from OMIM) ( NCI )] (UMLS (NCI) C1334944) Nerve Growth Factor Receptor Associated Protein 1;
Nerve Growth Factor Receptor-Associated Cell Death Executor;
NGFRAP1;
Ovarian Granulosa Cell Protein (13kD);
p75(NTR)-Associated Cell Death Executor =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 139. N-Acetyltyrosine
- (UMLS (NCI) C0067794) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 189. Nadene
- (UMLS (HL7) C1699250) =Language =AmericanIndianAlaskaNativeLanguages;
=Thlinget;
AthapaskanEyak |
- 140. N-butyl-N-(4-hydroxybutyl)nitrosamine
- [A synthetic carcinogenic compound found in a variety of smokes and industrial products, N-butyl-N-4-hydroxybutyl nitrosamine is used in biomedical research to induce transitional and squamous cell urinary bladder cancers and to promote experimental hepatocarcinogenesis, probably through abnormal DNA methylation. (NCI04) ( NCI )] (UMLS (NCI) C0006514) =Organic Chemical; Hazardous or Poisonous Substance
| - 190. NADH analog
- [ ] (UMLS (CSP) C0920600) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 141. N-butyl-N-nitroso-1-butanamine
- [A yellow, viscous, oily nitrosamine that is highly unstable in the presence of light. N-Nitrosodiethanolamine is ubiquitously found in the environment and is a contaminant formed by the reaction of nitrites with ethanolamines in a wide range of products including tobacco, pesticides, antifreeze and personal care products. This substance is only used for research purposes to induce tumors in experimental animals. N-Nitrosodiethanolamine is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0057809) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 191. NADH oxidoreductase
- [ ] (UMLS (CSP) C0682753) =Amino Acid, Peptide, or Protein; Enzyme
|
- 142. N-Hydroxy-N'-phenyloctanediamide
- [A substance that is being studied as an anticancer drug. ( NCI )] (UMLS (NCI) C0672708) =Organic Chemical; Pharmacologic Substance ;
| - 192. NADOLOL
- [A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, therefore inhibiting the effects of catecholamines, epinephrine, and norepinephrine. As a result, this agent produces negative inotropic and chronotropic effects. Nadolol exerts its antiarrhythmic effect via impairment of atrioventricular (AV) node conduction and reduction of sinus rate. In addition, nadolol blocks beta-2 adrenergic receptors located in the bronchiole smooth muscle resulting in vasoconstriction. Furthermore, beta-2 receptor blockage within the juxtaglomerular apparatus leads to the inhibition of renin production, as well as subsequent reduction in angiotensin II and aldosterone levels, thereby inhibiting angiotensin II and aldosterone dependent vasoconstriction and water retention. ( NCI )] (UMLS (NCI) C0027302) =Organic Chemical; Pharmacologic Substance ;
=Propanolamines;
[CV100] BETA-BLOCKERS/RELATED =NADOLOL 120 MG;
NADOLOL 20 MG;
NADOLOL 40 MG;
NADOLOL 80 MG;
NADOLOL 160 MG |
- 143. N-Lost
- (UMLS (NCI) C0701935) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance ;
| - 193. NADPH cytochrome c2 reductase
- [ ] (UMLS (CSP) C0311682) =Amino Acid, Peptide, or Protein; Enzyme =NAD(P)H oxidoreductase;
|
- 144. N-Methyl-N-Nitroso-Glycine
- [A pale yellow, crystalline solid nitrosamine that decomposes when exposed to light and emits toxic fumes of nitrogen oxides when heated to decomposition. N-Nitrososarcosine is used in laboratory research to induce tumors in experimental animals. This substance may be formed during the cooking of foods that contain sodium nitrite as a preservative, including meat, fish and cheese. Exposure to N-Nitrososarcosine irritates the skin and eyes. This substance is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0068238) =Organic Chemical; Hazardous or Poisonous Substance
| - 194. NADPH dehydrogenase
- [A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. ( MSH )] (UMLS (CSP) C0027312) =Amino Acid, Peptide, or Protein; Enzyme
|
- 145. N-TRAF BOARD/ALIGHT-DRIV
- [ ] (UMLS (ICD9CM) C0261179) =Phenomenon or Process
| - 195. NADPH Dependent Diflavin Oxidoreductase 1
- [Broadly expressed by human NR1 Gene (FNR Family), 597-aa 67-kDa cytoplasmic NADPH-Dependent FMN and FAD Containing Oxidoreductase is an enzyme homologous to cytochrome P-450 reductase that binds FMN, FAD, and NADPH cofactors, reduces cytochrome c, and metabolizes electron acceptors doxorubicin, menadione, and potassium ferricyanide. NR1 shares 41 to 44% similarity with nitric oxide synthase-2, methionine synthase transferase, and P-450 reductase. It may play a role in metabolic activation of bioreductive anticancer drugs and other chemicals activated by 1-electron reduction. (NCI) ( NCI )] (UMLS (NCI) C1312754) NADPH-Dependent FMN and FAD Containing Oxidoreductase;
NDOR1;
NR1 =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 146. N-TRAF BOARD/ALIGHT-PSGR
- [ ] (UMLS (ICD9CM) C0261180) =Phenomenon or Process
| - 196. NADPH oxidase
- [A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC. ( MSH )] (UMLS (CSP) C0068355) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 147. N-TRAF BRD/ALIGHT-MOCYCL
- [ ] (UMLS (ICD9CM) C0261181) =Phenomenon or Process
| - 197. Nadroparin
- [A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot. ( NCI )] (UMLS (NCI) C0206232) =Carbohydrate; Pharmacologic Substance
|
- 148. N-TRAF BRD/ALIT-ANIM RID
- [ ] (UMLS (ICD9CM) C0261184) =Phenomenon or Process
| - 198. Naegleria
- [free living soil amoeba pathogenic to humans and animals; occurs also in water and sewage; most commonly found species in man is Naegleri fowleri which is the pathogen for primary amebic meningoencephalitis in primates. ( CSP )] (UMLS (CSP) C0027320) =Invertebrate ;
=Sarcodina;
|
- 149. N-TRAF BRD/ALIT-MCYC PSG
- [ ] (UMLS (ICD9CM) C0261182) =Phenomenon or Process
| - 199. Nafcil
- (UMLS (NCI) C0733814) =Organic Chemical; Antibiotic ;
|
- 150. N-TRAF BRD/ALIT-PED CYCL
- [ ] (UMLS (ICD9CM) C0261185) =Phenomenon or Process
| - 200. NAFCILLIN
- [A semi-synthetic naphthalene and beta-lactam antibiotic with antibacterial activity. Nafcillin inhibits bacterial wall synthesis by a mechanism of action similar to penicillin. Penicillinase-resistant Nafcillin is used to treat infections caused by penicillin-resistant strains of Staphylococci. (NCI04) ( NCI )] (UMLS (NCI) C0027324) =Organic Chemical; Antibiotic =Penicillanic Acid;
[AM053] PENICILLINASE-RESISTANT PENICILLINS =NAFCILLIN SODIUM;
NAFCILLIN SODIUM MONOHYDRATE;
NAFCILLIN SODIUM;
NAFCILLIN SODIUM MONOHYDRATE;
|
home
